Howel–Evans syndrome
(Redirected from Tylosis with esophageal cancer)
Howel–Evans syndrome
Howel–Evans syndrome, also known as palmoplantar keratoderma with esophageal cancer, is a rare genetic disorder characterized by the development of thickened skin on the palms of the hands and soles of the feet (palmoplantar keratoderma) and an increased risk of developing esophageal cancer. This condition is inherited in an autosomal dominant pattern, meaning that a single copy of the altered gene in each cell is sufficient to cause the disorder.
Clinical Features[edit | edit source]
Individuals with Howel–Evans syndrome typically present with symptoms in early adulthood. The primary clinical features include:
- Palmoplantar keratoderma: Thickening of the skin on the palms and soles, which may be associated with pain and difficulty in walking or using the hands.
- Increased risk of esophageal cancer: Affected individuals have a significantly higher risk of developing squamous cell carcinoma of the esophagus, often in middle age.
Genetics[edit | edit source]
Howel–Evans syndrome is caused by mutations in the RHBDF2 gene, which is located on chromosome 17. The RHBDF2 gene is involved in the regulation of epidermal growth factor receptor (EGFR) signaling, which plays a crucial role in the maintenance and repair of the epidermis.
Diagnosis[edit | edit source]
The diagnosis of Howel–Evans syndrome is based on clinical evaluation, family history, and genetic testing. Key diagnostic criteria include:
- Presence of palmoplantar keratoderma
- Family history of similar skin changes and/or esophageal cancer
- Genetic testing confirming a mutation in the RHBDF2 gene
Management[edit | edit source]
Management of Howel–Evans syndrome involves regular monitoring and early detection of esophageal cancer. This may include:
- Regular endoscopic surveillance of the esophagus
- Treatment of palmoplantar keratoderma with topical keratolytics, emollients, and other supportive measures
- Genetic counseling for affected individuals and their families
Related Pages[edit | edit source]
- Palmoplantar keratoderma
- Esophageal cancer
- Autosomal dominant
- RHBDF2
- Epidermal growth factor receptor
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD